Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Permit To Import Controlled Substances for Domestic and/or Scientific Purposes Pursuant to 21 U.S.C. 952; DEA Form 357, 48270 [2020-17378]
Download as PDF
48270
Federal Register / Vol. 85, No. 154 / Monday, August 10, 2020 / Notices
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: August 5, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2020–17375 Filed 8–7–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0013]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Application for
Permit To Import Controlled
Substances for Domestic and/or
Scientific Purposes Pursuant to 21
U.S.C. 952; DEA Form 357
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until
September 9, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:31 Aug 07, 2020
Jkt 250001
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
with this collection: 497 annual burden
hours.
If additional information is required
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Permit to Import
Controlled Substances for Domestic
and/or Scientific Purposes Pursuant to
21 U.S.C. 952.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form: 357. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Diversion Control
Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): None.
Abstract: Section 1002 of the
Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 952) and
Title 21, Code of Federal Regulations
(21 CFR), Sections 1312.11, 1312.12 and
1312.13 requires any person who
desires to import controlled substances
listed in schedules I or II, any narcotic
substance listed in schedules III or IV,
or any non-narcotic substance in
schedule III which the Administrator
has specifically designated by regulation
in § 1312.30, or any nonnarcotic
substance in schedule IV or V which is
also listed in schedule I or II of the
Convention on Psychotropic
Substances, must have an import
permit. To obtain the permit to import
controlled substances for domestic and
or scientific purposes, an application for
the permit must be made to DEA on
DEA Form 357.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that 171
registrants participate in this
information collection, taking an
estimated 0.26 hours per registrant
annually.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: DEA estimates the
total public burden (in hours) associated
Dated: August 5, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
PO 00000
Frm 00122
Fmt 4703
Sfmt 4703
[FR Doc. 2020–17378 Filed 8–7–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request;
Certification of Funeral Expenses
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Office of
Workers’ Compensation Program
(OWCP)-sponsored information
collection request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that agency receives
on or before September 9, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Comments are invited on: (1) Whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) if the
information will be processed and used
in a timely manner; (3) the accuracy of
the agency’s estimates of the burden and
cost of the collection of information,
including the validity of the
methodology and assumptions used; (4)
ways to enhance the quality, utility and
clarity of the information collection; and
(5) ways to minimize the burden of the
SUMMARY:
E:\FR\FM\10AUN1.SGM
10AUN1
Agencies
[Federal Register Volume 85, Number 154 (Monday, August 10, 2020)]
[Notices]
[Page 48270]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17378]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0013]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection; Application for Permit To Import Controlled Substances for
Domestic and/or Scientific Purposes Pursuant to 21 U.S.C. 952; DEA Form
357
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 30 days until
September 9, 2020.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Application for Permit to Import
Controlled Substances for Domestic and/or Scientific Purposes Pursuant
to 21 U.S.C. 952.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: DEA Form: 357. The applicable
component within the Department of Justice is the Drug Enforcement
Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): None.
Abstract: Section 1002 of the Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal
Regulations (21 CFR), Sections 1312.11, 1312.12 and 1312.13 requires
any person who desires to import controlled substances listed in
schedules I or II, any narcotic substance listed in schedules III or
IV, or any non-narcotic substance in schedule III which the
Administrator has specifically designated by regulation in Sec.
1312.30, or any nonnarcotic substance in schedule IV or V which is also
listed in schedule I or II of the Convention on Psychotropic
Substances, must have an import permit. To obtain the permit to import
controlled substances for domestic and or scientific purposes, an
application for the permit must be made to DEA on DEA Form 357.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: DEA estimates that
171 registrants participate in this information collection, taking an
estimated 0.26 hours per registrant annually.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: DEA estimates the total public burden (in
hours) associated with this collection: 497 annual burden hours.
If additional information is required please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: August 5, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2020-17378 Filed 8-7-20; 8:45 am]
BILLING CODE 4410-09-P